Research ArticleOriginal Article
Open Access

Impact of COVID-19 on cancer management in military hospitals of Saudi Arabia

Omar Al Zahrani, Ismail Ghorbel, Osama Mukhtar, Muneera Almajed, Hoda M. Abdelazim, Muhammad N. Hasan, Ahmad Mostafa, Aisha A. Al Harbi and Ali Bajouda
Saudi Medical Journal December 2021, 42 (12) 1272-1280; DOI: https://doi.org/10.15537/smj.2021.42.12.20210483

References

  1. 1.↵
    1. Guan WJ,
    2. Ni ZY,
    3. Hu Y,
    4. Liang WH,
    5. Ou CQ,
    6. He JX, et al.
    Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–1720.
    OpenUrlCrossRefPubMed
  2. 2.↵
    World Health Organization. Coronavirus disease (COVID-19) outbreak. [Updated 2020; Accessed 2021 May 10]. Available from: https://www.who.int/emergencies/disease-outbreak-news
  3. 3.
    World Health Organization. Coronavirus disease (COVID-2019) situation reports. [Updated 2020; 2021 May 10]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  4. 4.↵
    1. Simcock R,
    2. Thomas TV,
    3. Estes C,
    4. Filippi AR,
    5. Katz MS,
    6. Pereira IJ,et al.
    COVID-19: Global radiation oncology’s targeted response for pandemic preparedness. Clin Transl Radiat Oncol 2020; 22: 55–68.
    OpenUrl
  5. 5.↵
    1. Raymond E,
    2. Thieblemont C,
    3. Alran S,
    4. Faivre S.
    Impact of the COVID-19 Outbreak on the management of patients with Target Oncol 2020; 15:249–259.
    OpenUrlCrossRef
  6. 6.↵
    1. Khare SR,
    2. Batist G,
    3. Bartlett G.
    Identification of performance indicators across a network of clinical cancer programs. Curr Oncol 2016; 23: 81–90.
    OpenUrl
  7. 7.↵
    1. van de Haar J,
    2. Hoes LR,
    3. Coles CE,
    4. Seamon K,
    5. Fröhling S,
    6. Jäger D, et al.
    Caring for patients with cancer in the COVID-19 era. Nat Med 2020; 26: 665–671.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Jazieh AR,
    2. Al Hadab A,
    3. Al Olayan A,
    4. AlHejazi A,
    5. Al Safi F,
    6. Al Qarni A, et al.
    (2020) Managing oncology services during a major coronavirus outbreak: lessons from the Saudi Arabia experience. JCO Glob Oncol 2020; 6: GO.20.00063.
  9. 9.↵
    1. Memish ZA,
    2. Perlman S,
    3. Van Kerkhove MD
    .Middle East respiratory syndrome. Lancet 2020; 395: 1063–1077.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Alessy SA,
    2. Davies EA,
    3. Jazieh AR.
    Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia. Ecancer 2020; 14: 1076.
    OpenUrl
  11. 11.↵
    Ministry of Health. Saudi Arabia National Cancer Institute (2020) Coronavirus Disease 2019 (COVID-19). Caregiver and Facility Clinical Practice Guidelines. [Updated 2020; Accessed 2021 February 15]. Available from: https://www.moh.gov.sa/Ministry/MediaCenter/Publications/Documents/Saudi-Arabia-National-Cancer.pdf
  12. 12.↵
    1. Algaissi AA,
    2. Alharbi NK, and
    3. Hassanain M
    , Hashem A. Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health 2020; 13: 834–838.
    OpenUrlPubMed
  13. 13.↵
    1. Neuss M,
    2. Rocque G,
    3. Zuckerman D,
    4. Chiang A,
    5. Katta S,
    6. Wollins D, et al.
    Establishing a core set of performance measures to improve value in cancer care: ASCO consensus conference recommendation report. J Oncol Pract 2017; 13: 135–140.
    OpenUrl
  14. 14.↵
    Ministry of Health. Coronavirus Disease COVID-19 Guidelines v1.2. [Updated 2020 March: Accessed 2021 February 15]. Available from: https://covid19.cdc.gov.sa/wp-content/uploads/2020/03/Coronavirus-Disease-2019-Guidelines-v1.2.pdf.pdf
  15. 15.↵
    1. Franchini AF,
    2. Auxilia F,
    3. Galimberti PM,
    4. Piga MA,
    5. Castaldi S,
    6. Porro A.
    COVID 19 and Spanish flu pandemics: All it changes, nothing changes. Acta Biomed 2020; 91: 245–250.
    OpenUrl
  16. 16.↵
    1. Alyami MH,
    2. Naser AY,
    3. Orabi MAA,
    4. Alwafi H,
    5. Alyami HS.
    Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: an ecological study. Front Public Health 2020; 8: 506.
    OpenUrl
  17. 17.↵
    National Health Service. Waiting Times for Suspected and Diagnosed Cancer Patients. 2016-2017 Annual Report. [Updated 2017; Accessed 2021 February 18 Available from: https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2017/06/Cancer-Waiting-Times-Annual-Report-201617-1.pdf
  18. 18.↵
    1. Jazieh AR,
    2. Akbulut H,
    3. Curigliano G,
    4. Rogado A,
    5. Alsharm AA,
    6. Razis ED, et al.
    Impact of the COVID-19 pandemic on cancer care: A global collaborative study. JCO Global Oncol 6: 1428–1438.
  19. 19. 19.↵
    1. Maringe C,
    2. Spicer J,
    3. Morris M,
    4. Purushotham A,
    5. Nolte E,
    6. Sullivan R, et al.
    The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 2020; 21: 1023–1034.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Zuliani S,
    2. Zampiva I,
    3. Tregnago D,
    4. Casali M,
    5. Cavaliere A,
    6. Fumagalli A, et al.
    Organisational challenges, volumes of oncological activity and patients’ perception during the severe acute respiratory syndrome coronavirus 2 epidemic. Eur J Cancer 2020; 135: 159–169.
    OpenUrl
  21. 21.↵
    1. De Joode K,
    2. Dumoulin DW,
    3. Engelen V,
    4. Bloemendal HJ,
    5. Verheij M,
    6. van Laarhoven HW, et al.
    Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer 2020 132–139.
  22. 22.↵
    1. Tashkandi E,
    2. BaAbdullah M,
    3. Zeeneldin A,
    4. AlAbdulwahab A,
    5. Elemam O,
    6. Elsamany S, et al.
    Optimizing the communication with cancer patients during the COVID-19 pandemic: patient perspectives. Patient Prefer Adherence 2020; 14: 1205–1212.
    OpenUrl
  23. 23.↵
    1. El Gohary GM,
    2. Hashmi S,
    3. Styczynski J,
    4. Kharfan-Dabaja MA,
    5. Alblooshi RM,
    6. de la Cámara R, et al.
    The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2020 S1658-3876: 30122–30129.
    OpenUrl
  24. 24.↵
    1. Salunke AA,
    2. Nandy K,
    3. Pathak SK,
    4. Shah J,
    5. Kamani M,
    6. Kotakotta V, et al.
    Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and meta-analysis. Diabetes Metab Syndr: Clin Res Rev 2020; 14: 1431–1437.
    OpenUrl
  25. 25.↵
    1. Yarza R,
    2. Bover M,
    3. Paredes D,
    4. López-López F,
    5. Jara-Casas D,
    6. Castelo-Loureiro A, et al.
    SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death Eur J Cancer 2020; 135: 242–250.
    OpenUrlPubMed
  26. 26.↵
    1. Kuderer NM,
    2. Choueiri TK,
    3. Shah DP,
    4. Shyr Y,
    5. Rubinstein SM,
    6. Rivera DR, et al.
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020; 395: 1907–1918.
    OpenUrlCrossRefPubMed
  27. 27. 27.↵
    1. Urun Y,
    2. Hussain SA,
    3. Bakouny Z,
    4. Castellano D,
    5. Kılıçkap S,
    6. Morgan G, et al.
    Survey of the Impact of COVID-19 on Oncologist’s Decision Making in Cancer. JCO Global Oncol 2020; 6: 1248–1257.
    OpenUrl
  28. 28.↵
    1. Angelis V,
    2. Tippu Z,
    3. Joshi K,
    4. Reis S,
    5. Gronthoud F,
    6. Fribbens C, et al.
    Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. Eur J Cancer 2020; 136: 99–106.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords